VEGFC and breast cancer: LyP-1 accumulated in the tumor lymphatics but not the tumor blood vessels of several tumor xenograft models including osteosarcomas, prostate and breast cancers, and metastatic lymph nodes of the vascular endothelial growth factor C (VEGF-C) overexpressing MDA-MB-435 tumors.